Fludarabine, Idarubicin, and Cytarabine (FLAI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fludarabine, Idarubicin, and Cytarabine (FLAI), covering 2020-02-24 to 2020-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome [Phase 1, Phase 2]